This nontypical regulatory mechanism of IκBα stability highlights the potential of circPCSK6‐167aa to indirectly modulate NF‐κB and proposes a unique “switch‐like” regulatory effect, suggesting that circPCSK6 may have broader applications in targeting multiple cancer‐related pathways simultaneously. Here, NFKB1 is linked to cancer.